Side-effects in women treated with adjuvant endocrine therapy for breast cancer

Many women with breast cancer prematurely discontinue adjuvant endocrine therapy, leading to increased mortality. We performed a cross-sectional survey (n = 456) within the Dutch UMBRELLA-cohort to gain insight into the prevalence of side-effects and its association with premature discontinuation. A...

Popoln opis

Bibliografske podrobnosti

Principais autores:	L.M. Rademaker, R. Gal, A.M. May, M.C.T. Batenburg, F. van der Leij, R.M. Bijlsma, H.M. Verkooijen, A. Doeksen, M.F. Ernst, D.J. Evers, C.C. van der Pol, E.M. Monninkhof
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2025-04-01
Serija:	Breast
Teme:	Adjuvant therapy Endocrine therapy ER positive Side-effects Discontinuation of therapy
Online dostop:	http://www.sciencedirect.com/science/article/pii/S0960977625000359
Oznake:	Označite Brez oznak, prvi označite!